A ging is a major risk factor for the development of cardiovascular disease, and age-related changes in vascular function are hypothesized to influence the progression of atherosclerosis. One of the hallmarks of aging tissues is an impaired ability to regenerate, caused by the accumulation of senescent cells. Cellular senescence is a state of irreversible growth arrest 1 that can be triggered via the progressive shortening of telomeres (DNA sequence repeats that protect the ends of chromosomes) with successive rounds of cell division, known as replicative senescence.
A ging is a major risk factor for the development of cardiovascular disease, and age-related changes in vascular function are hypothesized to influence the progression of atherosclerosis. One of the hallmarks of aging tissues is an impaired ability to regenerate, caused by the accumulation of senescent cells. Cellular senescence is a state of irreversible growth arrest 1 that can be triggered via the progressive shortening of telomeres (DNA sequence repeats that protect the ends of chromosomes) with successive rounds of cell division, known as replicative senescence. 2 Senescence can also be induced by a variety of cellular stresses, independently of extensive proliferation, including oxidative stress 3, 4 and activation of oncogenes. 5 The signaling pathways that promote cellular senescence vary according to the initiating stimulus, cellular context, and other factors. Senescence can be induced by p16 INK4A (p16) and p14 kinase inhibitor p21 WAF1/CIP1 (p21). These pathways converge because inhibition of cyclin-dependent kinases reduces phosphorylation of the retinoblastoma protein leading to inhibition of E2F transcription factors and expression of genes required for G1/S transition. Of note, the relative contribution of the p53-p21 and p16 tumor suppressor pathways to replicative and stress-induced senescence is a topic of much debate.
Cellular senescence is now attracting considerable interest in the cardiovascular field. Several studies have shown that telomere lengths in white blood cells are shorter in patients with atherosclerosis [9] [10] [11] [12] [13] [14] [15] compared with healthy controls, suggesting that replicative senescence may be involved in this disease. Moreover, telomere lengths decline with age in human arteries [16] [17] [18] and are shorter in coronary and carotid artery plaques compared with healthy vessels. 3, 19, 20 Increased activity of senescence-associated β-galactosidase (SA-β-gal) is commonly used to identify senescent cells. 21 Senescent cells are also associated with alterations in cellular morphology including enlargement, flattening, and multinucleation. Several studies have identified SA-β-gal-positive [22] [23] [24] or giant, multinucleated endothelial cells (ECs) overlying atherosclerotic plaques. [25] [26] [27] [28] EC senescence can be induced in arteries by repeated injury (presumably through replicative exhaustion) 29 and in response to various proatherogenic factors including tumor necrosis factor-α, reactive oxygen species, oxidized low-density lipoprotein, and angiotensin II. 3, 4, [30] [31] [32] By contrast, growth factors 33, 34 and NO 22, 35 protect ECs from entering the senescent state. Despite these insights, the molecular mechanisms that promote EC senescence in arteries and the role, if any, of senescent ECs in atherosclerosis are largely unknown.
Although atherosclerosis is associated with systemic risk factors such as age, high cholesterol, and obesity, plaque formation occurs predominately at branches and bends, whereas regions of uniform geometry are protected. 36, 37 The velocity and direction of blood flow, which varies according to vascular geometry and pulsatility, exhibits greater variation at atheroprone sites compared with protected regions. For example, biaxial or secondary flows are more prominent at atheroprone compared with protected sites. 36, 37 For the sake of brevity, we refer to flow patterns at atheroprone sites as disturbed and flow at protected sites as undisturbed. Here, we demonstrated that disturbed blood flow promotes EC senescence by activating p53-p21 signaling. Flow-induced senescent ECs had a reduced capacity for migration and displayed abnormal expression of inflammatory molecules, suggesting that they may be involved in vascular injury. Finally, we identified a potential intervention to suppress flowinduced senescence by demonstrating that this process can be inhibited by pharmacological activation of sirtuin 1.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
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Results
Although senescent ECs have been identified overlying atherosclerotic plaques, their potential role in plaque initiation and progression is uncertain. To address this, we quantified SA-β-gal-positive cells in en face preparations of aortae isolated from LDLR −/− (low-density lipoprotein receptor −/− ) mice. SA-β-gal staining at the aortic root, along the inner curvature, and at the major branches of the aortic arch was minimal in mice fed a normal chow diet but was enhanced in response to exposure to a high-fat diet for 2 to 12 weeks ( Figure 1A ). To confirm that SA-β-gal-positive cells were of endothelial origin, a fluorescent SA-β-gal substrate, dodecanoylaminofluorescein di-β-galactopyranoside (C 12 FDG), was used in conjunction with rhodamine-conjugated Griffonia lectin to identify ECs. En face staining revealed that the intensity of C 12 FDG was greater at the inner curvature (an atheroprone area exposed to disturbed flow) compared with the outer curvature (undisturbed flow region) and that the C 12 FDG signal was enhanced by exposure to a high-fat diet ( Figure 1B) . Similarly, en face staining studies in LDLR −/− mice demonstrated that high-fat feeding enhanced endothelial expression of p53 at the inner curvature but not at the outer curvature ( Figure 2 ). By contrast, p16 was not detected in murine aortae (data not shown). Studies using porcine aortae (≈6 months old) revealed SA-β-gal-positive staining at sites of disturbed flow including the origin of the left subclavian artery and brachiocephalic trunk and along the inner curvature of the aortic arch ( Figure IA in the online-only Data Supplement). SA-β-gal-positive staining was confirmed to be of endothelial origin by taking Häutchen preparations of the luminal layer ( Figure  IB in the online-only Data Supplement). These data suggest that senescent ECs accumulate at sites of disturbed flow.
Our in vivo observations led us to hypothesize that disturbed flow may promote EC senescence. To test this, we used an orbital shaking platform which generates reproducible spatially separated biaxial (disturbed) and uniaxial pulsatile (undisturbed) flow patterns. [39] [40] [41] CFD (computational fluid dynamics) analysis demonstrated that orbital shaking generated wall shear stress at the center of the well that had a relatively constant low magnitude but varied rapidly in direction ( Figure 3A) . Conversely, the periphery was associated with temporal fluctuations in the magnitude of wall shear stress, a relatively high maximum wall shear stress and relatively uniform direction ( Figure 3A) . We validated the orbital flow system by measuring the expression of transcripts that are known to be induced by disturbed (E-selectin) or undisturbed (endothelial NO synthase) flow. Cells at the center of orbiting wells expressed relatively high levels of E-selectin and low levels of endothelial NO synthase, whereas ECs at the periphery exhibited the opposite pattern ( Figure 3B ). Moreover, cells in the central region were not aligned, whereas cells in the periphery were elongated and aligned in the direction of the flow ( Figure 3C ) as described previously. 40, 41 We conclude that the orbital flow system generates spatially distinct flow fields and that cells in the center display morphological and transcriptional features that are characteristic of the response to disturbed flow. We used the orbital shaker platform to determine whether the application of disturbed or undisturbed flow for Figure 3C and Figure IIA in the online-only Data Supplement). Similarly, studies using syringe-pump flow bioreactor systems revealed that oscillatory flow induced cells that were SA-β-gal positive, large, and multinucleated, whereas undisturbed flow did not ( Figure IIB and IIC in the online-only Data Supplement). Thus, we conclude that EC senescence can be promoted by disturbed flow. Flow can influence EC proliferation. [43] [44] [45] Thus, we hypothesized that disturbed flow may induce EC senescence by promoting endothelial proliferation and consequent replicative exhaustion. To assess this, ECs were exposed to disturbed or undisturbed flow and proliferating cells were quantified by immunofluorescent staining using antibodies that recognize a marker of proliferation (Ki67; Figure IIIA in the online-only Data Supplement) or by measuring incorporation of EdU (5-ethyl-2ʹ-deoxyuridine), a fluorescent thymidine analogue (data not shown). ECs exposed to disturbed or undisturbed flow for 6 to 72 hours exhibited similar rates of proliferation ( Figure IIIA in the online-only Data Supplement) and cell counts ( Figure IIIB in the online-only Data Supplement), indicating that senescence did not result from increased proliferation at the disturbed flow site.
We examined the potential role of p53 in senescence because this transcription factor can be induced by disturbed flow 46 and it was expressed at a disturbed flow site in the murine aorta ( Figure 2 ). Single-cell analysis of proteins levels by immunofluorescent staining revealed that p53 and 
LDLR
−/− (low-density lipoprotein receptor −/− ) mice (aged 10 weeks) were fed a normal chow diet or high fat diet for 2 to 12 weeks. A, Aortae were opened on the greater curvature, and the luminal surfaces were assessed by colorimetric SA-β-gal staining. B, Aortae were analyzed by en face staining of the outer (undisturbed flow) and inner (disturbed flow) curvature using C 12 FDG (green), Griffonia lectin (red), and ToPro3 (purple). C 12 FDG fluorescence at undisturbed and disturbed sites was quantified, and data were pooled from 5 independent experiments.
p21 expression was strikingly elevated in senescent ECs compared with nonsenescent cells (exposed to either disturbed or undisturbed flow; Figure 4A ), and costaining revealed that p53 and p21 were coexpressed in senescent ECs ( Figure 4B ). Thus, the highest expression of p53 and p21 was restricted to senescent ECs exposed to disturbed flow. The mechanism is unlikely to involve changes at the transcript level because p53 mRNA levels were similar in ECs exposed to flow (disturbed or undisturbed) or static conditions, whereas p21 expression was elevated by undisturbed flow ( Figure IV in the online-only Data Supplement). The function of p53 and p21 was determined by gene silencing, which was confirmed by quantitative real-time polymerase chain reaction ( Figure  VA and VB in the online-only Data Supplement). In cultures exposed to disturbed flow, silencing of p53 ( Figure 4C ) or p21 ( Figure 4D ) significantly reduced the incidence of senescent cells. Interestingly, gene silencing revealed that p53 and p21 also positively regulated senescence in ECs exposed to static conditions or undisturbed flow, albeit at lower levels than under disturbed flow conditions ( Figure 4C and 4D) . Silencing of p53 reduced the expression of p21 in ECs ( Figure 4E ), indicating that p53 acts upstream of p21. Collectively, these data suggest that disturbed flow promotes EC senescence by activating a p53-p21 signaling pathway and that this pathway also influences the fate of cells exposed to undisturbed flow.
To assess the behavior and function of senescent ECs, we assessed their migratory capacity using the scratch wound healing assay coupled to live cell imaging. Human umbilical vein ECs were exposed to flow for 72 hours and then imaged under static conditions. Senescent ECs induced by disturbed flow migrated more slowly than surrounding nonsenescent cells ( Figure 5A ). Therefore, the accumulated and Euclidean distance migrated by senescent cells during the imaging period was significantly less when compared with the migration distance of surrounding nonsenescent cells ( Figure 5B and 5C ). Senescent ECs also impeded the migration of neighboring cells, whereas nonsenescent cells did not ( Figure 5A and 5C). These data indicate that senescent ECs have a reduced migratory capacity and also impede the migration of surrounding healthy cells. We conclude, therefore, that senescent ECs may impair wound healing and vascular repair in areas of disturbed flow.
The inflammatory phenotype of senescent ECs induced by disturbed flow was also assessed. Immunofluorescent staining was used to measure the expression of inflammatory adhesion molecules in senescent ECs in both basal conditions and after exposure to the inflammatory cytokine tumor necrosis factor-α. After staining for intercellular adhesion molecule-1 (ICAM-1), the mean fluorescence index (proportionate to the concentration of ICAM-1 over a given area of cell membrane) under either basal conditions or after tumor necrosis factor-α treatment was reduced in senescent ECs (p21 positive, large) compared with nonsenescent cells (Figure 5D and 5E). Interestingly, the total levels of ICAM-1 expressed in senescent ECs (calculated as mean fluorescence index×cell area) were similar to total ICAM-1 levels in healthy ECs ( Figure We examined whether the induction of senescence in ECs exposed to flow was regulated by sirtuin 1, a deacetylase that can function as a negative regulator of p53 signaling in some cell types. Silencing of sirtuin 1 ( Figure 6A and Figure VC in the online-only Data Supplement) or pharmacological inhibition of sirtuins (using the inhibitor sirtinol; Figure 6B ) promoted senescence in cells exposed to undisturbed flow but did not influence cells cultured under disturbed flow. We therefore concluded that sirtuin 1 protects ECs exposed to undisturbed flow from the induction of senescence. By contrast, we reasoned that ECs exposed to disturbed flow may be susceptible . Flow-induced senescence requires activation of p53 and p21 human umbilical vein endothelial cells (HUVECs) were exposed to orbital flow for 72 hours or to static conditions as a control. A, Immunofluorescent staining was performed using anti-p53 (green; upper) or anti-p21 (green; lower) antibodies and nuclei were counterstained using ToPro-3 (purple). Staining for senescence-associated β-galactosidase (SA-β-gal) was conducted in parallel, and positive cells are marked by arrows. Fluorescence of cells exposed to disturbed (center) or undisturbed (periphery) flow was assessed by laser scanning confocal microscopy, and representative images are shown. The expression of p53 and p21 in SA-β-gal-positive or SA-β-gal-negative cells at regions of disturbed flow (or in cells exposed to undisturbed flow) was quantified, and data from 4 independent experiments were pooled. Mean fluorescence values are shown with SEs. B, Costaining using anti-p53 (red) and anti-p21 (green) antibodies was performed. Nuclei were counterstained with ToPro-3 (purple). Fluorescence of cells exposed to disturbed (center) or undisturbed (periphery) flow was assessed by laser scanning confocal microscopy, and representative images are shown. Scale bar (bottom right) shows 50 μm. Rates of disturbed flow-induced senescence were assessed in HUVECs transfected with small interfering RNA (siRNA) targeting p53 (C) or p21 (D) relative to scramble-treated controls using the SA-β-gal assay. Mean values were pooled from 3 independent experiments and are shown with SDs. E, p21 expression was assessed by quantitative real-time polymerase chain reaction in sheared HUVECs transfected with p53 siRNA or nontargeting (scrambled) siRNA. Mean values pooled from 3 independent experiments are shown with SDs. MFI indicates mean fluorescence index.
to senescence because they express relatively low levels of sirtuin 1 (compared with cells exposed to undisturbed flow). To address this hypothesis, we used resveratrol, a polyphenol that is known to induce sirtuin 1 expression, 47 and SRT1720, which is a specific activator of sirtuin 1. Pretreatment of ECs using resveratrol (100 μmol/L) reduced the subsequent induction of senescent ECs by disturbed flow ( Figure 6C ). Suppression of sirtuin 1 by treatment with sirtinol ( Figure 6D ) Figure 5 . Disturbed flow-induced senescent endothelial cells (ECs) migrate less and exhibit reduced inflammatory activation. A to C, Human umbilical vein ECs (HUVECs) were exposed to disturbed flow for 72 hours. A scratch wound was then made in the monolayer, and cells were imaged for 18 hours. Senescence-associated β-galactosidase (SA-β-gal) staining was then performed and superimposed onto the live cell imaging data. This allowed migration trajectories to be plotted for SA-β-gal-positive (senescent) and SA-β-gal-negative (healthy) cells using ImageJ software (C, upper). Trajectories were also calculated for healthy cells located proximal to either SA-β-galpositive or SA-β-gal-negative cells (C, lower). Migration trajectories were used to calculate the migration velocities (A) and accumulated and Euclidean distances (B). The migration trajectories of ≈50 individual cells per experiment were assessed. Data were pooled from 4 independent experiments. D and E, HUVECs exposed to disturbed flow for 72 hours were exposed to tumor necrosis factor-α (TNF-α; 10 ng/mL for 18 hours) or remained untreated before costaining of intercellular adhesion molecule-1 (ICAM-1; red) and p21 (green). Nuclei were stained with ToPro-3 (purple) A and B, Human umbilical vein ECs (HUVECs) were transfected with Sirt1 small interfering RNA (siRNA) or scrambled sequences (100 nmol/L final concentration), or were treated with sirtinol (50 μmol/L) or with vehicle alone. Cells were then exposed to disturbed or undisturbed flow for 72 hours. Senescence rates were measured using the senescence-associated β-galactosidase (SA-β-gal) assay. Data were pooled from ≥3 independent experiments, and mean values are shown with SEs. C, HUVECs were treated with resveratrol (100 μmol/L) or with vehicle alone immediately before the application of disturbed flow for 72 hours. Senescence rates were measured using the SA-β-gal assay. Data were pooled from 6 independent experiments, and mean values are shown with SEs. D and E, HUVECs were pretreated with sirtinol (50 μmol/L) or with vehicle alone (D) or were transfected with Sirt1 siRNA or with a scrambled control (E). Cells were subsequently treated with resveratrol (100 μmol/L) or with vehicle alone before the application of disturbed flow for 72 hours. Senescence rates were measured using the SA-β-gal assay. Data were pooled from 3 independent experiments, and mean values are shown with SEs. F to H, HUVECs were treated with SRT1720 (20 μmol/L) or with vehicle alone immediately before the application of disturbed or undisturbed flow for 72 hours. G and H, Immunofluorescent staining was performed using anti-p21 antibodies (green), and ECs were identified using anti-CD31 antibodies (red). Nuclei were counterstained using ToPro-3 (purple). Fluorescence of cells exposed to disturbed or undisturbed flow was assessed by laser scanning confocal microscopy. F, Representative images are shown. G, The expression of p21 was quantified in multiple ECs, and data from 3 independent experiments were pooled. Mean fluorescence values are shown with SDs. H, Senescence rates were measured using the SA-β-gal assay. Data were pooled from 3 independent experiments, and mean values are shown with SDs.
or by gene silencing ( Figure 6E ) restored the induction of EC senescence by disturbed flow in resveratrol-treated cells, indicating that resveratrol protects ECs via sirtuin 1. Similarly, it was concluded that SRT1720 can protect ECs from senescence because treatment using this compound significantly reduced the induction of p21 ( Figure 6F and 6G) and activation of SA-β-gal ( Figure 6H ) in response to disturbed flow. Therefore, pharmacological induction of sirtuin 1 can suppress the induction of senescence by disturbed flow.
Discussion
Senescent ECs have previously been identified in advanced plaques, [22] [23] [24] but it is uncertain whether they influence early atherogenesis. We demonstrate here that ECs overlying early atherosclerotic lesions display several features that are characteristic of cellular senescence; specifically, they were enlarged, displayed high SA-β-gal activity, and expressed high levels of p53. The corollary to these observations is that EC senescence may be involved in atherosclerosis initiation and progression and may contribute to the focal nature of the disease. EC senescence can be induced in arteries by oxidized low-density lipoprotein, tumor necrosis factor-α, and other proatherogenic molecules. 3, 4, [30] [31] [32] The presence of senescent ECs at atheroprone sites in vivo may be related to local hemodynamics because we observed that senescent ECs accumulate under disturbed flow (but not undisturbed flow) conditions in vitro. We hypothesized that disturbed flow induces senescence as a consequence of enhanced proliferation because ECs at atheroprone sites display relatively high rates of turnover compared with those at protected sites. 43, 44 Although replicative senescence may occur at atheroprone sites in vivo, we observed that disturbed flow can induce senescence in the absence of increased cell turnover. These data imply that the senescent phenotype may be induced in ECs as a direct consequence of flow perturbation. The focal nature of EC senescence is related to wall shear stress, a force exerted on ECs by flowing blood that varies in time, magnitude, and direction according to vascular pulsatility and anatomy. 36, 48, 49 Shear stress influences many aspects of EC physiology, 36, 37, [48] [49] [50] and future studies should now be performed to examine whether mechanical stimulation can trigger the induction of senescence. This concept is novel because mechanical forces have not been previously linked to vascular aging processes. Interestingly, disturbed flow was sufficient to induce endothelial senescence in vitro, whereas senescent cells were induced at disturbed flow sites in vivo by high-fat feeding. Thus, although disturbed flow was involved in the induction of senescence in vivo, it was not sufficient to induce growth arrest in the absence of other cues. It is plausible that the generation of senescent cells in a disturbed flow environment requires a second stress signal. This signal may be present in vitro because cell isolation and culture is associated with physiological stresses (eg, hyperoxia). By contrast, ECs exposed to disturbed flow may receive a second stress signal in response to hypercholesterolemia. Disturbed flow has been shown to influence several functions including morphology, inflammatory activation, and apoptosis. 36, 37 Our observation that proliferating and senescent ECs coexist at sites of disturbed flow reinforces the concept that atheroprone sites are associated with considerable heterogeneity in cell phenotype. 36 Using a combination of immunostaining and gene silencing, we demonstrated that p53 and p21 activation were required for disturbed flow-induced senescence. These findings provide further evidence of the diversity and complexity of senescence induction. They align with previous studies demonstrating that the contribution of p53, p21, and p16 varies with the type of stimulus. [5] [6] [7] [8] p53 coordinates the cellular response to stress and is a key regulator of cell fate. Interestingly, previous studies revealed that p53 and p21 are activated by both disturbed and undisturbed flow, although the effects on cell fate were dissimilar. Undisturbed flow induces reversible growth arrest (quiescence) and protection from apoptosis via p53-mediated induction of p21 and GADD45. 45, 51, 52 Other studies have shown that disturbed flow promotes apoptosis via a mechanism that involves modification of p53 with SUMO (small ubiquitin-like modifier) and retention in the cytoplasm. 46 Together with our current study, which indicated a role for p53 in disturbed flowinduced senescence, these observations emphasize the pleiotropic nature of p53 which is influenced by blood flow patterns. Further studies should be performed to identify the molecular mechanisms that control p53 decision making in sheared ECs.
Senescent cells remain metabolically active and often acquire an altered transcriptional profile. As a consequence, they have the potential to modify the function of tissues in which they accumulate. Here, we demonstrate for the first time that senescent ECs migrate more slowly than surrounding nonsenescent ECs exposed to the same mechanical environment. This suggests that regions of the arterial tree where senescent cells accumulate may have an impaired capacity to repair. This has important implications in vivo in the context of plaque progression because dysfunctional repair mechanisms may promote local inflammatory activation and thrombosis. Senescent ECs can be considered proatherogenic in this regard. Paradoxically, although senescence has been associated with inflammation in other contexts, the induction of EC senescence by disturbed flow was associated with a reduced expression of ICAM-1 and vascular cell adhesion molecule-1 at the cell surface, suggesting potential antiatherogenic properties. These findings support recent observations that H 2 O 2 -induced senescent ECs, mediated via activation of the SENEX gene, express lower levels of proinflammatory proteins. 3 These observations emphasize the need for further research into the potential role of senescent ECs in atherosclerosis which is likely to be complex.
The NAD + (nicotinamide adenine dinucleotide)-dependent deacetylase sirtuin 1 negatively regulates p53 [53] [54] [55] [56] [57] by removing acetyl groups, thus enhancing p53 degradation via the ubiquitin ligase Mdm2. We observed using a small interfering RNAbased approach or using a pharmacological inhibitor (sirtinol) that sirtuin 1 protects against the induction of senescence in ECs which is consistent with a previous report. 54 Notably, pretreatment of ECs using resveratrol, found in grapes and red wine, inhibited senescence in response to disturbed flow via a sirtuin 1-dependent mechanism. Pretreatment with resveratrol also caused ECs in disturbed flow regions, which typically exhibit polygonal, cobblestone morphology, to become elongated (data not shown). We reason that this may be because of the actions of resveratrol on Krüppel-like factor 2 58 which has previously been shown to cause elongation of ECs under static conditions. 59 Although resveratrol can exert cardioprotective effects, [60] [61] [62] the physiological significance of these effects has been doubted because of its low bioavailability. 63 Nevertheless, our observations support the principle that pharmacological activation of sirtuin 1 may promote cardiovascular health by suppressing EC senescence at atheroprone sites. This concept is further substantiated by our observation that an alternative sirtuin 1 activator (SRT1720) can also reduce the induction of senescence by disturbed flow. We speculate that the mechanism may involve sirtuin 1-dependent deacetylation and deactivation of p53 to prevent cell cycle arrest; however, other possibilities exist because sirtuin 1 also negatively regulates cell cycle arrest by suppressing liver kinase B1/AMPK (AMPactivated protein kinase) 55 and nuclear factor κB 56 and by inducing NO. 54, 57 Our observations reveal a novel mechanism for the protective effects of sirtuin 1 in vascular ECs. They are consistent with previous reports that sirtuin 1 can protect against lesion formation in atherosclerosis-prone mice 64, 65 ; however, further studies using conditional sirtuin 1 knockouts are now required to define the cell types that are responsible for the protective effects of sirtuin 1 activation in vivo.
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Although atherosclerosis is associated with systemic risk factors such as age, high cholesterol, and obesity, plaque formation occurs predominately at branches and bends that are exposed to disturbed patterns of blood flow. The molecular mechanisms that link disturbed flow-generated mechanical forces with arterial injury and disease are uncertain. In this article, we show for the first time that senescent endothelial cells accumulate at regions of disturbed flow in arteries. We conclude that the mechanism is related to cellular biomechanical responses because disturbed flow induced senescence in cultured endothelial cells via a p53-p21-dependent pathway. The study also demonstrates that flow-induced senescent endothelial cells are dysfunctional in terms of migration and inflammatory activation and thus may contribute to arterial disease processes. Finally, we demonstrated that pharmacological activation of sirtuin 1 can protect endothelial cells from flow-regulated senescence, thus paving the way for the development of novel treatments for arterial injury.
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